Real-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year results
To provide 2-year follow-up data on eyes with diabetic macular edema (DME) that were non-responsive after three initial anti-vascular endothelial growth factor (VEGF) injections, comparing functional and anatomical outcomes under continued anti-VEGF therapy versus dexamethasone (DEX) implant.
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
21 September 2019
|
| In: |
Acta diabetologica
Year: 2019, Jahrgang: 56, Heft: 12, Pages: 1341-1350 |
| ISSN: | 1432-5233 |
| DOI: | 10.1007/s00592-019-01416-4 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00592-019-01416-4 |
| Verfasserangaben: | Catharina Busch, Samantha Fraser-Bell, Matias Iglicki, Marco Lupidi, Aude Couturier, Voraporn Chaikitmongkol, Ermete Giancipoli, Patricio J. Rodríguez-Valdés, Pierre-Henry Gabrielle, Inês Laíns, Ana Rita Santos, Zafer Cebeci, Atchara Amphornphruet, Valentin Degenhardt, Jan-Darius Unterlauft, Carlo Cagini, Valérie Mané-Tauty, Giuseppe D’Amico Ricci, Isaac Hindi, Kushal Agrawal, Jay Chhablani, Anat Loewenstein, Dinah Zur, Matus Rehak, for the International Retina Group |
| Zusammenfassung: | To provide 2-year follow-up data on eyes with diabetic macular edema (DME) that were non-responsive after three initial anti-vascular endothelial growth factor (VEGF) injections, comparing functional and anatomical outcomes under continued anti-VEGF therapy versus dexamethasone (DEX) implant. |
|---|---|
| Beschreibung: | Gesehen am 06.03.2020 |
| Beschreibung: | Online Resource |
| ISSN: | 1432-5233 |
| DOI: | 10.1007/s00592-019-01416-4 |